Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01170975 · ClinicalTrials.gov registry record · Phase 1
Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg Capsules
A Phase 1 study, sponsored by Genta Incorporated.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01170975 is a Phase 1 study that has completed, run by Genta Incorporated. The registered enrollment target is 12 participants.
The verdict
NCT01170975, a Phase 1 study, has completed, sponsored by Genta Incorporated.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study explores the effects of food (a high-fat meal) on the pharmacokinetics of tesetaxel.
Interventions
- DRUG Tesetaxel 10 mg with and then without food
- DRUG Tesetaxel 10 mg without and then with food
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01170975
The ClinicalTrials.gov registry entry for NCT01170975 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Genta Incorporated, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tesetaxel 10 mg with and then without food is the first listed.
NCT01170975 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01170975 about?
NCT01170975 is a clinical study titled "Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg Capsules". This study explores the effects of food (a high-fat meal) on the pharmacokinetics of tesetaxel.
What is the current status of trial NCT01170975?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2010-06. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01170975?
The interventions under investigation include: Tesetaxel 10 mg with and then without food (DRUG), Tesetaxel 10 mg without and then with food (DRUG).
Who is sponsoring clinical trial NCT01170975?
This trial is sponsored by Genta Incorporated, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.